1-(((4-((7-METHOXY-6-(SULFOOXY)-4-QUINOLINYL)OXY)PHENYL)AMINO)CARBONYL)CYCLOPROPANECARBOXYLIC ACID

Details

Stereochemistry	ACHIRAL
Molecular Formula	C21H18N2O9S
Molecular Weight	474.441
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of 1-(((4-((7-METHOXY-6-(SULFOOXY)-4-QUINOLINYL)OXY)PHENYL)AMINO)CARBONYL)CYCLOPROPANECARBOXYLIC ACID

Structure Search

SMILES

COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(O)=O)C=C3)=C2C=C1OS(O)(=O)=O

InChI

InChIKey=NGMVKHPJYUKGJR-UHFFFAOYSA-N

InChI=1S/C21H18N2O9S/c1-30-17-11-15-14(10-18(17)32-33(27,28)29)16(6-9-22-15)31-13-4-2-12(3-5-13)23-19(24)21(7-8-21)20(25)26/h2-6,9-11H,7-8H2,1H3,(H,23,24)(H,25,26)(H,27,28,29)

HIDE SMILES / InChI

Molecular Formula	C21H18N2O9S
Molecular Weight	474.441
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Wed Apr 02 05:32:33 GMT 2025` Edited by `admin` on `Wed Apr 02 05:32:33 GMT 2025`
Record UNII	NI7FZ38DO2
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CABOZANTINIB METABOLITE M2A

Preferred Name

English

1-(((4-((7-METHOXY-6-(SULFOOXY)-4-QUINOLINYL)OXY)PHENYL)AMINO)CARBONYL)CYCLOPROPANECARBOXYLIC ACID

Systematic Name

English

EXEL-1644

Common Name

English

CYCLOPROPANECARBOXYLIC ACID, 1-(((4-((7-METHOXY-6-(SULFOOXY)-4-QUINOLINYL)OXY)PHENYL)AMINO)CARBONYL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

NI7FZ38DO2

Created by admin on Wed Apr 02 05:32:33 GMT 2025 , Edited by admin on Wed Apr 02 05:32:33 GMT 2025

PRIMARY

PUBCHEM

86269669

Created by admin on Wed Apr 02 05:32:33 GMT 2025 , Edited by admin on Wed Apr 02 05:32:33 GMT 2025

PRIMARY

CAS

1628530-37-9

Created by admin on Wed Apr 02 05:32:33 GMT 2025 , Edited by admin on Wed Apr 02 05:32:33 GMT 2025

PRIMARY

Related Record Type Details


					B46KUN2O9L

MATE-2

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					66DDF797LP

OATP-8

TRANSPORTER -> SUBSTRATE


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> SUBSTRATE


					PUO0521HZV

CYTOCHROME P450 3A4

METABOLIC ENZYME -> SUBSTRATE


					AIN96D6SGL

OATP1B1

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					4AF605U6JN

MRP-2

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					L0423Z5LDW

CYTOCHROME P450 2C8

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					66DDF797LP

OATP-8

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					081I12ZA58

CYTOCHROME P450 2C19

METABOLIC ENZYME -> SUBSTRATE


					ZWJ2Y6JZWY

OAT-3

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					76UB6O122H

ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2

TRANSPORTER -> SUBSTRATE


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> INHIBITOR

Qualification:

IC50

Amount:


					L9DP834D1P

CYTOCHROME P450 2C9

METABOLIC ENZYME -> SUBSTRATE


					I81U7H57XI

OAT-1

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					WCI46BYD7T

BSEP

TRANSPORTER -> INHIBITOR

Qualification:

IC50

Amount:


					ZWJ2Y6JZWY

OAT-3

TRANSPORTER -> SUBSTRATE


					AIN96D6SGL

OATP1B1

TRANSPORTER -> SUBSTRATE


					4AF605U6JN

MRP-2

TRANSPORTER -> SUBSTRATE

Related Record Type Details


					1C39JW444G

Cabozantinib

PARENT -> METABOLITE

Interaction Type:

MAJOR

Qualification:

PLASMA

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC